FOLH1 and posterior cortical atrophy: Similarly, PSMA-PET may represent a prognostic tool and could replace conventional imaging in selected high-risk PCa patients before primary treatment, due to its higher diagnostic accuracy for N and M staging (1, 23); thus, increasing interest emerged for a PSMA-based treatment.